Control Bionics (ASX: CBL) secures German reimbursement for NeuroNode, fueling Europe wholesale push and distributor ramp-up amid funding risks.

Virginia Chamlee is a Politics Writer at PEOPLE. She has been working at PEOPLE for three years. Her work has previously appeared in The Washington Post, Buzzfeed, Eater, and other outlets. Dave ...

GEORGETOWN, Texas (KXAN) — Kai Pollnitz sat in, what he later learned, was a fake doctor’s office in North Carolina this December when a man in scrubs and a mask walked in with a shiny blue box.

Control Bionics has signed a deal with Tobii Dynavox, a global leader in augmentative and alternative communication (AAC) solutions, to explore a distribution partnership, offering its NeuroNode ...

A 12-year-old was surprised with his first bionic arm by YouTube megastar Jimmy Donaldson – known as MrBeast. Kai Pollnitz, who was born without his right hand, received the custom-built prosthetic at ...

Add Yahoo as a preferred source to see more of our stories on Google. In a new Instagram carousel posted to Wagner's page, scroll over to the fifth photo to see the actress reunited with Majors ...

In a recent study, researchers from China have developed a chip-scale LiDAR system that mimics the human eye's foveation by dynamically concentrating high-resolution sensing on regions of interest ...

In this post, we will show you how to enable or disable Spatial Sound in Windows 11. Spatial Sound is an advanced audio feature that creates an immersive, 3D sound experience, without requiring ...

LOS ANGELES, Jan. 15, 2026 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) for ...

Forbes contributors publish independent expert analyses and insights. A former tech executive covering AI, XR and The Metaverse for Forbes. Spatial Design, Breaking the 2D Paradigm, a new book by ...

Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...